- Riociguat, an oral soluble guanylate cyclase stimulator, in the treatment of pulmonary hypertension2016 | First Faculty of Medicine
- Riociguat - the first proven effective pharmacotherapy in patients with unresectable and residual chronic thromboembolic pulmonary hypertension2014 | First Faculty of Medicine
- Riociguat for the treatment of chronic thromboembolic pulmonary hypertension2013 | First Faculty of Medicine
- Identifying potential parameters associated with response to switching from a PDE5i to riociguat in RESPITE2020 | First Faculty of Medicine
- Sensitive CE-MS method for monitoring of riociguat and desmethylriociguat levels in human serum2020 | First Faculty of Medicine, Faculty of Science, Third Faculty of Medicine
- Development of a CE-MS method for the study of riociguat and metabolite M1 in pharmaceutical analysis2019 | First Faculty of Medicine, Faculty of Science
- Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access study2017 | Publication without faculty affiliation
- The pharmacology treatment of a chronic thromboembolic pulmonary hypertension - the case report2019 | First Faculty of Medicine
- Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): open-label, long-term extension of a phase 2b, randomised, placebo-controlled trial2023 | First Faculty of Medicine
- Indirect treatment comparison and cost-minimization analysis of riociguat versus selexipag in patients with pulmonary arterial hypertension2022 | First Faculty of Medicine, Faculty of Social Sciences
- The impact of riociguat on clinical parameters and quality of life in patients with chronic thromboembolic pulmonary hypertension - results of a retrospective clinical registry2021 | First Faculty of Medicine
- Chronic thromboembolic pulmonary hypertension2016 | First Faculty of Medicine
- A severe right heart failure as a result of chronic thromboembolic pulmonary hypertension2019 | First Faculty of Medicine
- Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension2017 | First Faculty of Medicine
- Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2)2015 | First Faculty of Medicine
- Population pharmacokinetics of riociguat and its metabolite in patients with chronic thromboembolic pulmonary hypertension from routine clinical practice2020 | First Faculty of Medicine, Faculty of Science
- Efficacy and safety of riociguat in combination therapy for patients with pulmonary arterial hypertension (PATENT studies)2020 | First Faculty of Medicine
- Effect of riociguat on right ventricular function in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension2021 | First Faculty of Medicine
- Surgical treatment of chronic thromboembolic pulmonary hypertension2019 | First Faculty of Medicine
- RESPITE: switching to riociguat in pulmonary arterial hypertension patients with inadequate response to phosphodiesterase-5 inhibitors2017 | First Faculty of Medicine
- Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trial2020 | First Faculty of Medicine
- Chronická tromboembolická plicní hypertenze - závažná komplikace akutní plicní embolie2016 | First Faculty of Medicine
- Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial2021 | First Faculty of Medicine
- Acute hemodynamic effects of Riociguat in patients with pulmonary hypertension associated with diastolic heart failure (DILATE-1)2014 | First Faculty of Medicine
- Predictors of long-term outcomes in patients treated with riociguat for chronic thromboembolic pulmonary hypertension: data from the CHEST-2 open-label, randomised, long-term extension trial2016 | First Faculty of Medicine
- Predictors of long-term outcomes in patients treated with riociguat for pulmonary arterial hypertension: data from the PATENT-2 open-label, randomised, long-term extension trial2016 | First Faculty of Medicine
- Plicní hypertenze - doporučení ESC/ČKS2016 | First Faculty of Medicine
- Chronic thromboembolic pulmonary hypertension: role of medical therapy2013 | First Faculty of Medicine
- Operability assessment in CTEPH: Lessons from the CHEST-1 study2016 | First Faculty of Medicine